1. Home
  2. MURA vs JG Comparison

MURA vs JG Comparison

Compare MURA & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • JG
  • Stock Information
  • Founded
  • MURA 2013
  • JG 2012
  • Country
  • MURA Ireland
  • JG China
  • Employees
  • MURA N/A
  • JG N/A
  • Industry
  • MURA
  • JG Computer Software: Programming Data Processing
  • Sector
  • MURA
  • JG Technology
  • Exchange
  • MURA Nasdaq
  • JG Nasdaq
  • Market Cap
  • MURA 36.0M
  • JG 38.9M
  • IPO Year
  • MURA N/A
  • JG 2018
  • Fundamental
  • Price
  • MURA $2.10
  • JG $6.76
  • Analyst Decision
  • MURA Buy
  • JG
  • Analyst Count
  • MURA 2
  • JG 0
  • Target Price
  • MURA $6.00
  • JG N/A
  • AVG Volume (30 Days)
  • MURA 112.3K
  • JG 5.3K
  • Earning Date
  • MURA 11-06-2025
  • JG 11-13-2025
  • Dividend Yield
  • MURA N/A
  • JG N/A
  • EPS Growth
  • MURA N/A
  • JG N/A
  • EPS
  • MURA N/A
  • JG N/A
  • Revenue
  • MURA N/A
  • JG $50,967,244.00
  • Revenue This Year
  • MURA N/A
  • JG $10.90
  • Revenue Next Year
  • MURA N/A
  • JG N/A
  • P/E Ratio
  • MURA N/A
  • JG N/A
  • Revenue Growth
  • MURA N/A
  • JG 20.78
  • 52 Week Low
  • MURA $0.95
  • JG $4.30
  • 52 Week High
  • MURA $4.74
  • JG $20.94
  • Technical
  • Relative Strength Index (RSI)
  • MURA 51.21
  • JG 41.54
  • Support Level
  • MURA $2.06
  • JG $6.18
  • Resistance Level
  • MURA $2.10
  • JG $7.11
  • Average True Range (ATR)
  • MURA 0.02
  • JG 0.37
  • MACD
  • MURA -0.00
  • JG 0.06
  • Stochastic Oscillator
  • MURA 50.00
  • JG 60.53

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

Share on Social Networks: